AI tool aims to predict deadly repeat cardiac arrests in real time
NCT ID NCT07452016
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a machine learning device that uses heart tracings (ECG) to predict if a person will have another cardiac arrest after being revived. Researchers will first see if EMS providers find the device useful in simulated scenarios, then test its accuracy in 68 real patients. The goal is to help emergency teams treat rearrests faster and improve survival.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
machine learning-guided cardiac arrest prediction device
What this could lead to
If successful, this device could help EMS providers predict and treat recurrent cardiac arrest faster, potentially improving survival rates.
What could go wrong
This is an early feasibility study with only 68 participants, testing accuracy and usability, not yet proven to save lives. The device may not work as well in real-world conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUDDEN CARDIAC ARREST are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The MetroHealth System
Cleveland, Ohio, 44109, United States
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact